-
+6 +1Cocaine haul seized from couple in 70s on UK cruise ship
Drugs were hidden in four suitcases on ship returning to Essex from Caribbean, police say
-
+43 +6Dark web dealers voluntarily ban deadly fentanyl
Suppliers, fearing police crackdown, decide opioid is too high-risk to trade
-
+15 +1People on love drug MDMA still know who to trust
For recreational users, ecstasy has long been associated with a harmonious mindset. Now there’s research to back that up. In a new study of MDMA, ecstasy’s main ingredient, the drug indeed made people more cooperative—but only with trustworthy partners.
-
+1 +1Can Toad Venom Unlock The Mystery Of Neurogenesis? New Insights on 5-MeO-DMT | Psychedelic Times
2018 has been an incredible time for advances in psychedelic research, including psilocybin mushrooms, ketamine and more, not to mention a landmark year for MDMA and cannabis. Meanwhile, some research on a much lesser known psychedelic, 5-MeO-DMT, has slipped past national attention. Known as 5-methoxy-N,N-dimethyltryptamine, this potent little molecule is most famous for occurring in …
-
+31 +7The making of an opioid epidemic
The long read: When high doses of painkillers led to widespread addiction, it was called one of the biggest mistakes in modern medicine. But this was no accident
-
+26 +6Is a recent fall in overdose deaths temporary or a sign of a corner turned?
Public health experts say they see reason to be optimistic but warned against drawing firm conclusions based on a half-year’s worth of data.
-
+33 +7Report says the UN's global 'war on drugs' has been a failure
The United Nations' drug strategy of the past 10 years has been a failure, according to a major report by the International Drug Policy Consortium (IDPC), which has called for a major rethinking of global policy on illegal narcotics.
-
+2 +1Beyond Psilocybin: Mushrooms Have Lots of Cool Compounds Scientists Should Study - The Crux
Mushrooms contain many unexplored compounds that could help humanity.
-
+14 +3Drug companies will have to publish list prices a new rule
Drug companies will have to give list prices for their products in television ads under a new proposal the Trump administration released Monday. The new rule, which is open for discussion, would affect any drug covered by Medicare or Medicaid. Health and Human Services Secretary Alex Azar announced the new proposal just hours after the lobby group that represents big drug companies said its members would start indirectly mentioning prices in their television ads.
-
+19 +4Newly developed fentanyl strips help alert drug users of a hidden danger
The strip detects fentanyl, the cheap synthetic opioid, mixed with street drugs – that’s been blamed for the surge of overdose deaths. It’s controversial because helping drug users test their supplies could be seen as advocating abuse.
-
+12 +2Georgia mom accidentally smothers baby during fatal meth overdose, sheriff says
A 31-year old woman who died from a methamphetamine overdose accidentally smothered her 8-month-old son, a Cherokee County sheriff’s spokesman said. The bodies were found July 17 in a home on Cedar Mill Crossing in Acworth, sheriff’s spokesman Jay Baker said Friday in a statement. The woman’s 2-year-old daughter was discovered in the home unharmed and is with family members.
-
+9 +1B.C. tables bill to clear the way for lawsuit against opioid makers
The British Columbia government has tabled legislation aimed at fast-tracking a lawsuit against dozens of players in the opioid industry that it says knowingly spread misinformation and downplayed the addictive properties of the drugs, contributing to the overdose crisis. Attorney-General David Eby said the Opioid Damages and Health Care Costs Recovery Act, introduced on Monday, would help “facilitate the introduction of evidence” to expedite the class-action lawsuit announced in late August.
-
+1 +1In Defense of Juul, After the Latest Media Hit-Piece
The media frenzy against Juul, the US market leader in vaping products, is on steroids. The latest hit-piece was published ...
-
+3 +1Hopkins researchers recommend reclassifying psilocybin, the drug in 'magic' mushrooms, from schedule I to schedule IV
Psilocybin safety and abuse research shows that the drug has low potential for abuse and dependence, researchers say
-
+1 +1Safe Drug Injection Sites Do Save Lives After All - D-brief
A controversial study claimed legal drug use sites – like many cities want to open - don’t prevent overdoses. The publisher retracted the research citing human error.
-
+33 +10Congratulations. Your Study Went Nowhere.
Researchers should embrace negative results instead of accentuating the positive, which is one of several biases that can lead to bad science.
-
+8 +1Reclassification Recommendations for Drug in ‘Magic Mushrooms’
In an evaluation of the safety and abuse research on the drug in hallucinogenic mushrooms, Johns Hopkins researchers suggest that if it clears phase III clinical trials, psilocybin should be re-categorized from a schedule I drug—one with no known medical potential—to a schedule IV drug such as prescription sleep aids, but with tighter control.
-
+19 +2Antidepressants might fail if you use your phone in bed, study suggests
Monash University research raises the prospect of a link between antidepressants and light sensitivity.
-
+1 +1The Strange Realm of Salvia Research | Psychedelic Times
Salvia is best known as somewhat of a meme—the goofy, over-the-counter psychedelic prevalent in head shops, notorious for its uncomfortable, short-lived hallucinogenic trip. Pretty much harmless, but a way that many young psychonauts get their toes wet. But the herb Salvia divinorum carries great cultural significance in some parts of the world, and research into …
-
+21 +3Cocaine ads
Right from the seventies & eighties onto your screen. You can't snort pixels.
Submit a link
Start a discussion




















